Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity

Lupus

Volumn 6, Issue 2, 1997, Pages 193-202

  Furukawa, F ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cutaneous; Lupus erythematosus; Model; Murine; Photosensitivity

Indexed keywords

ANIMAL MODEL; ARTICLE; NONHUMAN; PHOTOSENSITIVITY; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031040387     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600215     Document Type: Article

References (88)

1. Andrews BS et al. Spontaneous murine lupus-like syndrome, clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198-1215.
2. Steinberg AD. Insights into the basis of systemic lupus. J Autoimmunity 1995; 8: 771-785.
3. Theofilopoulos AN, Dixon FJ. Etiopathogenesis of murine SLE. Immunol Rev 1981; 55: 179-216.
4. Murphy ED, Roths JB. Autoimmunity and lymphoproliferation. Induction by mutant gene Ipr , and acceleration by a male-associated factor in strain BXSB mice. In: Bigazzi PE, Warner NL (eds). Genetic Control of Autoimmune Disease Elsevier: New York, 1978; pp 207-221.
5. Furukawa F et al. Pathogenesis of lupus dermatoses in autoimmune mice. IV. association betewen cutaneous immunoglobulin deposition and anti-single-stranded DNA antibodies in sera. Arch Dermatol Res 1985; 277: 79-83.
6. Furukawa F et al. New horizons in murine lupus dermatoses. Proc Jpn Soc Invest Dermatol 1986; 10: 57-62.
7. Izui S et al. Mechanisms of genetic control of murine systemic lupus erythematosus. Springer Semin Immunopathol 1994; 16: 133-152.
8. Furukawa F et al. Genetic studies on the skin lupus band test in New Zealand mice. Clin Exp Immunol 1985; 59: 146-152.
9. Furukawa F et al. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 1984; 276: 186-194.
10. Furukawa F et al. Spontaneous autoimmune skin lesions of MRL/n mice - autoimmune disease-prone genetic background in relation to Fas-defect MRL/lpr mice. J Invest Dermatol 1996; 107: 95-100.
11. Watanabe-Fukunaga R et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
12. Kanauchi H, Furukawa F, Imamura S. Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol 1991; 96: 478-483.
13. Horiguchi Y et al. Ultrastructural lupus band test in skin of MRL/1 mice. Arch Dermatol Res 1986; 278: 474-480.
14. Provost TT, Watson R. The MRL/lpr mouse model of cutaneous lupus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus (4th edn). Lea & Febiger: Philadelphia, 1993, pp 282.
15. Horiguchi Y et al. Ultrastructural observations of skin lesions in MRL mice - dermoepidermal junction. Arch Dermatol Res 1984; 276: 229-234.
16. Horiguchi Y, Furukawa F, Imamura S. Ultrastructural observations of skin lesions in MRL mice - dermal infiltrations and capillary changes. J Dermatol 1986; 6: 440-447.
17. Furukawa F et al. The uterus lupus band test and its correlation with the skin lupus band test in autoimmune mice. Microbiol Immunol 1986; 30: 395-400.
18. Horiguchi Y et al. Comparative electron and immunoelectron microscopic studies on immunoglobulin deposits in the glomeruli of the kidney, skin, esophagus and uterus of MRL/1 mice Acta Histochem Cytochem 1987; 20: 217-227.
19. Furukawa F et al. Pathogenesis of lupus dermatoses in autoimmune mice. VI. correlation between positivity of lupus band test and lupus nephritis. Arch Dermatol Res 1986; 278: 343-346.
20. Kitajima T et al. Histological detection of c-myb and c-myc protooncogene expression in infiltrating cells in cutaneous lupus erythematosus-like lesions of MRL/1 mice by in situ hybridization. Clin Immunol Immunopathol 1992; 62: 119-123.
21. Furukawa F, Kanauchi H, Imamura S. Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology 1994; 189 (suppl. 1): 18-23.
22. Theofilopoulos AN. The basis of autoimmunity: Part II, Genetic predisposition. Immunol Today 1995; 16: 150-159.
23. Takahashi S et al. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 1991; 147: 515-519.
24. Gyotoku Y et al. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/Mp-lpr/lpr mice. J Immunol 1987; 138: 3785-3792.
25. Velthuis PJ et al. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies. Ann Rheum Dis 1990; 49: 163-167.
26. Burrows NP et al. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J Cutan Pathol 1993; 20: 159-162.
27. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 1978; 271: 67-69.
28. Galoppin L, Saurat JH. In vitro study of the binding of antiribonucleoprotein antibodies to the nucleus of isolated living keratinocytes. J Invest Dermatol 1981; 76: 264-267.
29. 1 hybrid and the correlation to renal disease. J Immunol 1983; 130: 740-746.
30. Shirai T et al. Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Arthritis Rheum 1986; 29: 242-250.
31. Furukawa F, Ohshio G, Imamura S. Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp -+/+ mice. Arch Dermatol Res 1993; 285: 20-26.
32. Berney T et al. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol 1992; 4: 93-99.
33. Horiguchi Y et al. Effects of ultraviolet light irradiation on the skin of MRL/1 mice. Arch Dermatol Res 1987; 279: 478-483.
34. Furukawa et al. Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes. J Invest Dermatol 1993; 101: 191-195.
35. Bielschowsky M, Helyer BJ, Howie JB. Spontaneous anemia in mice of the NZB/BL strain. Proc Univ Otago Med Sch 1959; 37: 9-11.
36. Howie JB, Helyer BJ. The immunology and pathology of NZB mice. Adv Immunol 1968; 9: 2215-266.
37. Shirai T. The genetic basis of autoimmunity in murine lupus. Immunol Today 1982; 7: 187-194.
38. Kono DH et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994; 91: 10168-10172.
39. 1 mice. Proc Natl Acad Sci USA 1994; 91: 4062-4066.
40. 1 hybrid mice. J Immunol 1975; 114: 133-137.
41. 1 mice: association with epidermal DNA synthesis. J Invest Dermatol 1979; 72: 25-28.
42. Furukawa F, Hamashima Y. Lupus band test in New Zealand mice and MRL mice. J Dermatol 1982; 9: 467-471.
43. Nakamura K et al. Spontaneous degenerative polyarthritis in male New Zealand Black/KN mice. Arthritis Rheum 1991; 34: 171-179.
44. Furukawa F. Pathogenesis of autoimmune alopecia. Rinsho Hifuka (in press) (in Japanese).
45. Tamada Y et al. Pathological studies on NC mouse with erythema and alopecia. Jpn J Allergol 1976; 25: 829-836.
46. Kondo K, Nagami T, Teramoto S. Differences in hematopoietic death among inbred strains of mice. In Bond PV and Sugahara T (eds). Comparative cellular and Species Radiosensitivity Igakushoin; Tokyo, 1969, pp 20-29.
47. 1 mouse, a new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988; 167: 2017-2022.
48. 1 mice to β2-glycoprotein I and cardiolipin. J Immunol 1996; 156: 2631-2641.
49. 1 hybrid mice. J Clin Invest 1994; 94: 521-525.
50. 1 mice: a new model of lupus-like disease. J Exp Med 1994; 179: 1429-1435.
51. Sontheimer RD. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol 1996; 63: 583-594.
52. Natali PG, Tan EM. Experimental skin lesions in mice resembling systemic lupus erythematosus. Arthritis Rheum 1973; 16: 579-589.
53. Imamura S. Skin lesion of SLE and its pathomechanisms. Nishinihon J Dermatol 1981; 43: 1119-1125 (abstract in English)
54. Epstein JH, Tuffanelli DL, Dubois EL. Light sensitivity and lupus erythematosus. Arch Dermatol 1965; 91: 483-485.
55. Kochevar IE. Action spectrum and mechanisms of UV radiation-induced injury in lupus erythematosus. J Invest Dermatol 1985; 85: 140S-143S.
56. Halpern B, Emerit I, Housset E. Possible autoimmune processes related to chromosomal abnormalities (breakage) in NZB mice. Nature 1972; 235: 214-215.
57. Reddy AL, Fialkow PJ, Salo A. Ultraviolet radiation-induced chromosomal abnormalities in fetal fibroblasts from New Zealand black mice. Science 1978; 201: 920-922.
58. Emerit I. Chromosome breakage factors: origin and possible significance. Proc Muta Res 1982; 4: 61-74.
59. Zamanski GB et al. Effect of ultraviolet light irradiation on the survival of New Zealand black mouse cells. Arthritis Rheum 1980; 23: 866-867.
60. Natali PG, Mottolese M, Nicotra M. Immune complex formation in NZB/W mice after ultraviolet radiation. Clin Immunol Immunopathol 1978; 10: 414-419.
61. Davis P, Percy JS. Effect of ultraviolet light on disease characteristics of NZB/W mice. J Rheumatol 1978; 5: 125-128.
62. Ansel JC et al. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB mice. J Invest Dermatol 1985; 85: 181-186.
63. Furukawa F, Lyons MB, Norris DA. Susceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol 1989; 52: 460-472.
64. Golan DT, Borel Y. Increased photosensitivity to near-ultraviolet light in murine SLE. J Immunol 1984; 132: 705-710.
65. McGrath Jr H. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 129-135.
66. Gleichmann E, Van Elven EH, Van der Veen JPW. A systemic lupus erythematosus(SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 1982; 12: 152-159.
67. 1 mice. J Immunol 1983; 130: 2693-2701.
68. Gelpi C et al. Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins. J Immunol 1988; 140: 4160-4166.
69. Appleby P, Webber DG, Bowen JG. Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development. Clin Exp Immunol 1989; 78: 449-453.
70. Girardi M, Herreid P, Tigelaar RE. Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes. J Invest Dermatol 1995; 104: 177-182.
71. Maeda T, Nomoto K. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels. J Rheumatol 1995; 22: 2259-2265.
72. Vladutiu AO. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 1993; 93: 1-8.
73. Duchosal MA et al. Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med 1990; 172: 985-988.
74. 1 pre-B cells. J Exp Med 1992; 176: 1343-1353.
75. Segal R et al. Induction of experimental systemic lupus erythematosus (SLE) in mice with severe combined immunodeficiency (SCID). Clin Exp Immunol 1992; 89: 239-243.
76. Sneller MC et al. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr /gld disease. J Clin Invest 1992; 90: 334-341.
77. Dauphinee MJ et al. Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol 1981; 127: 2483-2487.
78. Tang B et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991; 3: 273-278.
79. Finck BK, Chan B, Wofsy D. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 1994; 94: 585-591.
80. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995; 144: 157-193.
81. Takahashi S et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996; 97: 1597-1604.
82. Dang H et al. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-b knockout mice. J Immunol 1995; 155: 3205-3212.
83. Shoenfeld Y. Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc 1994; 26: 3211-3213.
84. Gilkeson GS et al. Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. Clin Immunol Immunopathol 1992; 64: 166-172.
85. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994; 265: 1225-1227.
86. Kanauchi H, Imamura S, Takigawa M, Furukawa F. Effects of cyclosporin A on lupus dermatoses in autoimmune-prone MRL/Mp-lpr /lpr mice. J Dermatol Treat 1994; 5: 187-191.
87. Kanauchi H, Imamura S, Takigawa M, Furukawa F. Evaluation of the Japanese-Chinese herbal medicine, Kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol 1994; 21: 935-939.
88. Furukawa F, Imamura S, Takigawa M. KF506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res 1995; 287: 558-563.